Award for infliximab 20ML vials; base year with 4 one year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79718D0033
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$117,496,798.08
Award type
Single award
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00021 · Incorporation of drug supply chain security act (dscsa) language $0
Supplemental Agreement for work within scope P00020 · Incorporation of federal ceiling pricing into contract in accordance with public law 102-585. No changes to awarded national contract price. $0
Add Subcontract Plan P00019 · Incorporate the 2023 approved small business subcontracting plan $0
Exercise an Option P00018 · Exercise the final option year 4 effective september 1, 2022 to august 31, 2023 for infliximab injections with organon, LLC $0
Other Administrative Action P00017 $0
Supplemental Agreement for work within scope P00016 · Remove old NDC from contract. $0
Supplemental Agreement for work within scope P00014 · Incorporate the 2022 federal ceiling price. No change to contract pricing. $0
Add Subcontract Plan P00015 · Incorporate the 2022 approved subk plan. $0
Novation Agreement P00012 · Modification is issued to incorporate novation of contractor from merck sharp & dohme corp. To organon, LLC. $0
Add Subcontract Plan P00013 · Incorporate the 2021 subk plan as apart of the novation. $0
Supplemental Agreement for work within scope P00011 · Incorporate NDC changes into contract. $0
Exercise an Option P00010 · Exercise the third option year for infliximab contract 36E79718D0033 with merck sharp & dohme corp. With price change. $0
Add Subcontract Plan P00009 · To incorporate the 2021 approved subk plan. $0
Supplemental Agreement for work within scope P00008 · To incorporate the 2021 federal ceiling prices (FCP). There is no change to current national contract prices as they are lower then FCP. $0
Other Administrative Action P00007 · Administrative change for POC and updated authorized negators list. $0
Exercise an Option P00006 · Exercise the second option year for infliximab contract 36E79718D0033 with merck sharp & dohme corp. With price changes as originally awarded with increasing… $0
Other Administrative Action P00005 · Correction to data in modification P00004 (2020 FCP modification). $0
Supplemental Agreement for work within scope P00004 · 2020 public law updates. $0
Exercise an Option P00003 · Exercise option year 1 for infliximab with merck sharp & dohme corp. With price increase $0
Add Subcontract Plan P00002 · Incorporate 2019 approved subk plan $0
Supplemental Agreement for work within scope P00001 · 2019 public law updates. $0
Original award $0
Show all 22

Quick answers

Who was awarded contract 36E79718D0033?

36E79718D0033 was awarded to Organon LLC by National Acquisition Center (Headquarters) on September 1, 2018.

How much is contract 36E79718D0033 worth?

36E79718D0033's own ceiling is $117,496,798.

Who can order from contract 36E79718D0033?

36E79718D0033 is a single award indefinite delivery contract.

Was contract 36E79718D0033 competed?

The extent of competition for 36E79718D0033 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login